Study S001296

The Effect of Liraglutide on MMC Activity, Gastrointestinal Hormones, Hunger Ratings and ad Libitum Food Intake in Healthy Volunteers

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04008290
Acronym: LIRHV
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: UNKNOWN
Enrollment: 15
Start: 2020-04-01
Primary completion: 2021-04-01
Lead sponsor: Universitaire Ziekenhuizen KU Leuven
Conditions: Obesity
Interventions: DRUG:0.6 mg Liraglutide; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

MMC activity compared between placebo and treatment with liraglutide [The catheter will be placed 1 hour before the subcutaneous administration. Antroduodenal contractility will be measured for 5 hours after liraglutide or placebo injection.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.